Toolkit/photocyclic animal opsins

photocyclic animal opsins

Construct Pattern·Research·Since 2025

Also known as: artificial photocyclic opsins

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

This review would like to focus on the unique photocyclic animal opsin ... and also discuss the possibility of designing "artificial photocyclic opsins" from natural opsins for potential application in optogenetic gene therapy.

Usefulness & Problems

Why this is useful

Photocyclic animal opsins are described as animal opsins whose activity can be controlled by a photocyclic reaction, enabling light-driven cycling between states. The review also discusses designing artificial versions from natural opsins.; optogenetic gene therapy; light-controlled switching between dark and active states

Source:

Photocyclic animal opsins are described as animal opsins whose activity can be controlled by a photocyclic reaction, enabling light-driven cycling between states. The review also discusses designing artificial versions from natural opsins.

Source:

optogenetic gene therapy

Source:

light-controlled switching between dark and active states

Problem solved

The source frames these opsins as a possible route to optogenetic gene therapy by providing controllable light-responsive behavior in animal opsins.; designing animal opsins with photocyclic or photoreversible control properties

Source:

The source frames these opsins as a possible route to optogenetic gene therapy by providing controllable light-responsive behavior in animal opsins.

Source:

designing animal opsins with photocyclic or photoreversible control properties

Problem links

designing animal opsins with photocyclic or photoreversible control properties

Literature

The source frames these opsins as a possible route to optogenetic gene therapy by providing controllable light-responsive behavior in animal opsins.

Source:

The source frames these opsins as a possible route to optogenetic gene therapy by providing controllable light-responsive behavior in animal opsins.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Target processes

No target processes tagged yet.

Input: Light

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: actuator

requires design from natural opsins; depends on photocyclic reaction mechanisms described in the source

The abstract does not show a therapeutic demonstration or establish that any engineered photocyclic opsin already works in gene therapy settings.; application is discussed as a possibility rather than demonstrated in the abstract

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1application potentialsupports2025Source 1needs review

Artificial photocyclic opsins may be designed from natural opsins for potential application in optogenetic gene therapy.

Approval Evidence

1 source1 linked approval claimfirst-pass slug photocyclic-animal-opsins
This review would like to focus on the unique photocyclic animal opsin ... and also discuss the possibility of designing "artificial photocyclic opsins" from natural opsins for potential application in optogenetic gene therapy.

Source:

application potentialsupports

Artificial photocyclic opsins may be designed from natural opsins for potential application in optogenetic gene therapy.

Source:

Comparisons

Source-stated alternatives

The abstract contrasts photocyclic opsins with mono-stable vertebrate rhodopsin and bistable opsins such as Opn4 and Opn5.

Source:

The abstract contrasts photocyclic opsins with mono-stable vertebrate rhodopsin and bistable opsins such as Opn4 and Opn5.

Source-backed strengths

framed as potentially useful for optogenetic gene therapy; draws on natural opsin diversity and photocycle mechanisms

Source:

framed as potentially useful for optogenetic gene therapy

Source:

draws on natural opsin diversity and photocycle mechanisms

Compared with opsins

The abstract contrasts photocyclic opsins with mono-stable vertebrate rhodopsin and bistable opsins such as Opn4 and Opn5.

Shared frame: source-stated alternative in extracted literature

Strengths here: framed as potentially useful for optogenetic gene therapy; draws on natural opsin diversity and photocycle mechanisms.

Relative tradeoffs: application is discussed as a possibility rather than demonstrated in the abstract.

Source:

The abstract contrasts photocyclic opsins with mono-stable vertebrate rhodopsin and bistable opsins such as Opn4 and Opn5.

Ranked Citations

  1. 1.
    StructuralSource 1MED2025Claim 1

    Seeded from load plan for claim c5. Extracted from this source document.